Concepedia

Publication | Open Access

CD200 Expression in Neuroendocrine Neoplasms

DOIFull Paper Access

36

Citations

19

References

2017

Year

Jason E. Love, Kim D. Thompson, Mark Kilgore, Maria Westerhoff, Claire Murphy, Antonios Papanicolau‐Sengos, Kinsey A. McCormick, Veena Shankaran, Natalie Vandeven, Faith G. Miller,
American Journal of Clinical Pathology

Abstract

CD200 is a relatively sensitive marker of neuroendocrine neoplasms and represents a potential therapeutic target in these difficult-to-treat malignancies.

References

YearCitations

Page 1